🔎 Trials Near Me

Почетна › Гојазност › Ilinois › Chicago

Kliničke studije za Гојазност u gradu Chicago, IL

29 studija za Гојазност traži učesnike na lokacijama u gradu Chicago i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Тражи се учесникФаза 3
  • Research Site, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Тражи се учесникФаза 2
  • Charter Research LLC - Chicago, Chicago
  • Flourish Research, Ravenswood Rheumatology, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07685808

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

Тражи се учесникФаза 3
  • Northwestern Medicine, Chicago
  • Northwestern Memorial Hospital, Diagnostic Testing Center (Phlebotomy/EKG), Chicago
  • Northwestern Memorial Hospital, Investigational Drug Service, Chicago
  • и још 2
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Тражи се учесникФаза 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Тражи се учесникФаза 3
  • Cedar Crosse Research Center, Chicago
  • Northwestern University, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Тражи се учесникФаза 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Тражи се учесникФаза 3
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07353931

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Тражи се учесникФаза 3
  • Rush University Medical Center, Chicago
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Тражи се учесникФаза 3
  • Rush University Medical Center, Chicago
Узраст од 18 до 70 · Оба пола · Ажурирано 4. 11. 2026. · NCT06937086

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Тражи се учесникФаза 3
  • Ann and Robert Lurie Children's Hospital of Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Тражи се учесникФаза 3
  • Research Site, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Тражи се учесникФаза 3
  • Research Site, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Тражи се учесникФаза 2
  • Great Lakes Clinical Trials - West Wilson Avenue /ID# 282378, Chicago
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07752979

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Тражи се учесникФаза 2
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07589608

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Тражи се учесникФаза 2
  • Great Lakes Clinical Trials - Ravenswood, Chicago
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT06143956

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Тражи се учесникФаза 3
  • Chicago Research Center, Inc, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07571109

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Тражи се учесникФаза 3
  • Flourish Research - Great Lakes Clinical Trials, Chicago
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684235

A Trial to Examine the Effects of a Weight Loss Program Emphasizing Protein, Dietary Fiber, and Exercise (30-30-30 Plan)

Тражи се учесникЗдраве особе су добродошле
  • Illinois Institute of Technology, Chicago
Узраст од 18 до 69 · Оба пола · Ажурирано 5. 10. 2026. · NCT07789769

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Тражи се учесникФаза 3
  • Great Lakes Clinical Trials, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Тражи се учесникФаза 3
  • Chicago Research Center, Inc, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07668414

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Тражи се учесникФаза 3
  • University Of Chicago, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 11. 9. 2026. · NCT07571005

BRIDGE & Friends Trial

Тражи се учесникЗдраве особе су добродошле
  • University of Illinois Chicago, Chicago
Узраст од 50 до 79 · Оба пола · Ажурирано 1. 9. 2026. · NCT07798557

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Тражи се учесникЗдраве особе су добродошле
  • Illinois Institute of Technology, Chicago
Узраст од 21 до 74 · Оба пола · Ажурирано 27. 8. 2026. · NCT07566325

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Тражи се учесникФаза 3
  • ACCOMPLISH-1 Research Site, Chicago
Узраст од 18 до 79 · Оба пола · Ажурирано 10. 8. 2026. · NCT07654361

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Тражи се учесник
  • Jesse Brown VA Medical Center, Chicago
Узраст 18 и старији · Оба пола · Ажурирано 22. 7. 2026. · NCT06390345

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

Тражи се учесникФаза 2
  • Mile Square Health Center Chicago, Chicago
  • Mile Square Health Center - Auburn Gresham, Chicago
  • Mile Square Health Center - Englewood, Chicago
  • и још 1
Сви узрасти · Оба пола · Ажурирано 10. 7. 2026. · NCT07332741

Better Lifestyle Counseling for African American Women During Pregnancy

Тражи се учесник
  • University of Illinois at Chicago, Chicago
  • University of Illinois at Chicago, Chicago
Узраст од 18 до 40 · Жене · Ажурирано 9. 7. 2026. · NCT05234125

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

Тражи се учесникОпсервациона студија
  • Northwestern Memorial Hospital, Chicago
Узраст од 18 до 70 · Оба пола · Ажурирано 17. 3. 2026. · NCT07207148

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Тражи се учесникФаза 3
  • University of Chicago, Chicago
Узраст од 18 до 75 · Оба пола · Ажурирано 14. 11. 2025. · NCT06499857

Studije za Гојазност u drugim gradovima

Ostale studije u gradu Chicago

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.